10.09 USD
▼-0.12-1.18%
盘后 11.35 0.00%
2026-09-15
市值
$162.50M
市盈率
—
EPS
-3.86
股息率
—
52 周区间
9.62 – 16.77
成交量
274.56K
Beta
0.93
目标价
25.00
52W 低 9.6252W 高 16.77
价格走势
公司简介
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company’s development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. It has a research collaboration and license a...